COVID-19 vaccine capacity: Challenges and mitigation - The DCVMN perspective
Autor: | Sai Prasad, Benoit Hayman, Rajinder Kumar Suri |
---|---|
Rok vydání: | 2021 |
Předmět: |
2019-20 coronavirus outbreak
clinical trials Vaccines COVID-19 Vaccines General Veterinary General Immunology and Microbiology Coronavirus disease 2019 (COVID-19) technology transfer SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Short Communication Public Health Environmental and Occupational Health Stakeholder Developing country COVID-19 Variety (cybernetics) Infectious Diseases Risk analysis (engineering) Vaccine manufacturing Technology transfer Molecular Medicine Humans Business vaccine supply Developing Countries |
Zdroj: | Vaccine |
ISSN: | 1873-2518 |
Popis: | Vaccine manufacturers from developing countries have a proven track record of developing, producing, and supplying high-quality vaccines globally. However, due to the complexity of vaccine manufacturing, numerous stakeholder organizations support manufacturers across a variety of functions. To optimize the support from stakeholders it is instrumental to first understand which manufacturing processes these manufacturers require support for and what support functions are most beneficial. To this end, the Developing Countries Vaccine Manufacturers Network designed a comprehensive survey to assess the specific needs of the Network's member organizations. We found that almost all sampled manufacturers are interested in obtaining funding or technology transfers for COVID-19 vaccines. Furthermore, results indicated that manufacturers have a strong appetite for modern technology platforms, particularly RNA technologies. Scale-up, phase III clinical trials, and formulation were also key processes for which manufacturers require support. |
Databáze: | OpenAIRE |
Externí odkaz: |